Predictors of Reduced Opioid Use With Spinal Cord Stimulation in Patients With Chronic Opioid Use.
Mark C DoughertyRoyce W WoodroffeSaul WilsonGeorge T GilliesMatthew A HowardRyan M CarnahanPublished in: Neuromodulation : journal of the International Neuromodulation Society (2019)
With only half of chronic opioid users demonstrating meaningful opioid reduction after SCS implantation, we demonstrate that current SCS technology does not reliably help a larger number of patients reduce opioid usage. Women, older age, and preoperative MED < 65 are predictive of meaningful opioid reduction but only one of these is modifiable. As not all patients saw benefit from their therapies, there is still much room for improvement in the treatment of refractory chronic pain that is associated with failed back surgery syndrome and chronic regional pain syndrome.
Keyphrases
- chronic pain
- end stage renal disease
- pain management
- spinal cord
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- minimally invasive
- spinal cord injury
- type diabetes
- adipose tissue
- pregnant women
- acute coronary syndrome
- polycystic ovary syndrome
- neuropathic pain
- skeletal muscle
- coronary artery bypass
- middle aged
- surgical site infection